Drug Pipeline

ARDT Clinical Trials

Data updated daily from ClinicalTrials.gov — last refresh 2026-06-12
3
Active Studies
0
Recruiting
2
Phase 3
1
Top Sponsors
Active Studies by Phase
Phase 3
2
Phase 2
1
Active Trials
NCT IDTitleConditionStatus
Phase 3
NCT04689828 177Lu-PSMA-617 vs. Androgen Receptor-Directed Therapy in the Treatment of Progressive… Prostatic Neoplasms Active, Not Recruiting
NCT04720157 An International Prospective Open-label, Randomized, Phase III Study Comparing… Prostatic Neoplasms Active, Not Recruiting
Phase 2
NCT05658003 A Study Evaluating [177Lu]Lu-PSMA-617 vs. a Change of Androgen Receptor-directed Therapy… Metastatic Castration-Resistant Prostate Cancer (mCRPC) Active, Not Recruiting
Sponsors Running ARDT Trials
Novartis Pharmaceuticals (3)
Disease Areas
Prostate Cancer (1)
Get alerts when ARDT trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free